Clinical Trial Update: Study of Paclitaxel in Patients With Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating paclitaxel in patients with epithelial ovarian cancer, primary peritoneal cancer, and fallopian tube cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Oasmia Pharmaceutical AB | Conditions: Epithelial Ovarian Cancer, Primary Peritoneal Cancer | Phase 3 | Status: COMPLETED